| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/07/2006 | CN1784420A Method for the production of an N-terminally modified chemotactic factor |
| 06/07/2006 | CN1784419A Streptococcus agalactiae antigens i + ii |
| 06/07/2006 | CN1784146A Peptides having an ace inhibiting effect |
| 06/07/2006 | CN1784145A Hydrolysed casein product comprising tripeptides ipp and/ or vpp |
| 06/07/2006 | CN1782079A Wheat seed hardness relative gene and its coded protein and use |
| 06/07/2006 | CN1782071A Recombinant mva virus and the use thereof |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781943A South China sea conus littertus linnaeus nervotoxin and its coding sequence and use |
| 06/07/2006 | CN1781942A Corn succharose transporb carrier protein and its coding gene and use |
| 06/07/2006 | CN1781941A Protein Akaan 1 extracted from antrodia camphorata and its use in regulating immune function |
| 06/07/2006 | CN1781940A A group of long acting anti-retrovirus polypeptides and their preparing method and use |
| 06/07/2006 | CN1258594C Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof |
| 06/07/2006 | CN1258593C Putrescine-N-methyl transferase promoter |
| 06/07/2006 | CN1258539C Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 06/07/2006 | CN1258538C Recombinant protein |
| 06/07/2006 | CN1258537C Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 06/07/2006 | CN1258379C Botulinum toxin pharmaceutical composition |
| 06/06/2006 | US7057165 Probe for mass spectrometry |
| 06/06/2006 | US7057100 transgenic seeds, plants; improved herbicide, insect and disease resistance; modified fatty acid and carbohydrate metabolism; male sterility |
| 06/06/2006 | US7057088 Genetic engineered transgenic plant; controlling,germination |
| 06/06/2006 | US7057087 Application of aspen MADS-box genes to alter reproduction and development in trees |
| 06/06/2006 | US7057086 Treating eating, tumor, nervous system, systemic amyloidosis, myelofibrosis, glomerulosclerosis, atherosclerosis and age related disorders; animal models |
| 06/06/2006 | US7057029 membrane/transport proteins; pharmacogenetics; drug screening |
| 06/06/2006 | US7057028 14273 Receptor, a novel G-protein coupled receptor |
| 06/06/2006 | US7057023 From recombinant mammalian cells; for rope, cable, cord, twine, yarn, fishing line, netting, clothing/container/ tent fabric, bullet-proof vest lining, pool cover/vehicle cover, medical suture, sports equipment |
| 06/06/2006 | US7057022 Antibodies which specifically bind to TNF-R |
| 06/06/2006 | US7057021 Nucleotide sequences coding enzymatic polypeptide for use in detection and treatment of cancer |
| 06/06/2006 | US7057020 Isolated RuvB polypeptides |
| 06/06/2006 | US7057019 Crosslinked albumin hydrogels |
| 06/06/2006 | US7057018 Pro 1474 polypeptides |
| 06/06/2006 | US7057017 Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 06/06/2006 | US7057016 Process for the production of biologically active protein |
| 06/06/2006 | US7057015 Hormone receptor functional dimers and methods of their use |
| 06/06/2006 | US7057013 TGFβ1 inhibitor peptides |
| 06/06/2006 | US7057012 PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 06/06/2006 | US7056954 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 06/06/2006 | US7056888 Isolated from Bacillus; for controlling Lepidotera |
| 06/06/2006 | US7056886 GLP-2 formulations |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056882 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| 06/06/2006 | US7056740 Preparing preferential amino acid sequences in vitro; detecting restriction fragment length polymorphisms |
| 06/06/2006 | US7056737 Polynucleotides encoding a novel glycine receptor alpha subunit expressed in the gastrointestinal tract, HGRA4, and splice variant thereof |
| 06/06/2006 | US7056735 Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator) |
| 06/06/2006 | US7056734 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof |
| 06/06/2006 | US7056729 Botulinum neurotoxin-substance P conjugate or fusion protein for treating pain |
| 06/06/2006 | US7056710 Methods for producing ML-236B, a pravastatin precursor, using a host cell transformed with mlcR, a transcription factor |
| 06/06/2006 | US7056702 Immunoglobulin for detecting inflammation and bacterial infections in mammals |
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | US7056698 Nucleic acids encoding interleukin-9 receptor variants |
| 06/06/2006 | US7056697 FabK variant |
| 06/06/2006 | US7056695 TNF-α variants |
| 06/06/2006 | US7056692 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta |
| 06/06/2006 | US7056687 Methods and compositions for screening for altered cellular phenotypes |
| 06/06/2006 | US7056685 Receptor ligands and methods of modulating receptors |
| 06/06/2006 | US7056684 Comprises tyrosine kinase receptor ligand/prohibitin protein complex for diagnosis, prevention and treatment of diabetes, cancer, osteoporosis, cardiovascular and neurodegenerative diseases |
| 06/06/2006 | US7056683 Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities |
| 06/06/2006 | US7056681 For modulating cytokine, interferon, and tumor necrosis factor levels |
| 06/06/2006 | US7056680 Antibody binding; gene therapy; genetic mapping |
| 06/06/2006 | US7056677 Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them |
| 06/06/2006 | US7056667 Spatial learning and memory |
| 06/06/2006 | US7056666 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 06/06/2006 | US7056662 Reducing the level of circulating free fatty acids by administering a compound that inhibits mal1, especially inhibiting transcription or translation of mal1 |
| 06/06/2006 | US7056658 Epitope sequence for use as tool in diagnostic analysis |
| 06/06/2006 | US7056655 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 06/06/2006 | US7056521 Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| 06/06/2006 | US7056519 Methods for inducing HIV-neutralizing antibodies |
| 06/06/2006 | US7056518 Malarial pre-erythrocytic stage polypeptide molecules |
| 06/06/2006 | US7056517 Glucosyltransferase immunogens |
| 06/06/2006 | US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/06/2006 | US7056515 Antigens for immunocontraception |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | US7056512 controlling and increasing muscle growth, especially in farm animals for slaughter, by administering an immunogenically effective amount ofa modified GDF-8 polypeptide |
| 06/06/2006 | US7056511 contacting said cells with a free light chain of immunoglobulin-binding peptide having a specific amino sequence; may be used to treat asthma, allergy, including contact allergy and occupational allergy, chronic inflammatory bowel disorders, viral infection, multiple sclerosis. and migraines |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/06/2006 | US7056509 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 06/06/2006 | US7056508 Receptor-type phosphotyrosine phosphatase-kappa antibodies |
| 06/06/2006 | US7056505 Antibody for use in the diagnosis, prevention and treatment of infections, autoimmune disorders, arthritis, graft rejection and graft-versus-host disease |
| 06/06/2006 | US7056501 used to develop diagnostic assays for the detection of Neospora infections in cattle and other animals |
| 06/06/2006 | US7055461 Methods for growing and imprinting fish using an odorant |
| 06/06/2006 | CA2386587C Genes and proteins for the biosynthesis of anthramycin |
| 06/06/2006 | CA2318813C Highly efficient controlled expression of exogenous genes in e. coli |
| 06/06/2006 | CA2301044C Antimicrobial peptide and dna construct and expression system thereof |
| 06/06/2006 | CA2120153C Recombinant immunotoxins |
| 06/06/2006 | CA2116980C Chimeric and/or growth-restricted flaviviruses |
| 06/06/2006 | CA2071214C Method of delivering molecules into eukaryotic cells |
| 06/06/2006 | CA2053288C Expression of human apolipoproteins ai and ai-milano in yeast |
| 06/06/2006 | CA1341506C Factor viii coagulant polypeptides and monoclonal antibodies to them |
| 06/03/2006 | CA2526272A1 Polypeptides involved in candida biofilm formation and uses thereof |
| 06/01/2006 | WO2006058300A2 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 06/01/2006 | WO2006058226A2 Modified dimeric streptavidins and uses thereof |
| 06/01/2006 | WO2006057917A2 Hemipteran 5ht1 receptor |
| 06/01/2006 | WO2006057633A2 Method for designing polypeptides for the nanofabrication of thin films, coatings and microcapsules by electrostatic layer-by-layer self assembly. |
| 06/01/2006 | WO2006057500A1 Use of aimp2dx2 for the diagnosis and treatment of cancer |
| 06/01/2006 | WO2006057462A1 Peptide migrating into chromoplast in petal and method of constructing plant having yellowish petal by using the peptide |
| 06/01/2006 | WO2006057454A1 A method of prime-boost vaccination |
| 06/01/2006 | WO2006057389A1 Novel transcriptional factor phosphorylated by amp protein kinase and gene thereof |
| 06/01/2006 | WO2006057217A1 Dfrp proteins regulating drg proteins and utilization of the same |
| 06/01/2006 | WO2006056987A2 Leptin antagonists |